IMAX (NYSE: IMAX) director Richard Gelfond sells 121,220 shares for $4.86M

Rhea-AI Filing Summary

IMAX reported a Form 144 sale: Richard Gelfond sold 121,220 shares of Common Stock on 03/10/2026, reported with an aggregate value of $4,860,837.15. The filing lists Common shares on the NYSE and shows 53,993,017 shares cited with a 04/02/2026 date.

Insights

Corporate Governance Analyst

Insider sale reported; size is routine relative to outstanding shares.

The filing documents a 03/10/2026 disposition of 121,220 shares by Richard Gelfond via a cashless exercise/same-day sale reported on Form 144. The disclosed aggregate value is $4,860,837.15.

Relative scale matters: the reported 53,993,017 shares (as of 04/02/2026) imply the sale is a small percentage of outstanding equity. Subsequent filings may show whether this was part of routine compensation liquidity or other planning.

Key Figures

Shares sold: 121,220 shares Aggregate value reported: $4,860,837.15 Shares cited outstanding: 53,993,017 shares +1 more

4 metrics

Shares sold 121,220 shares Sale date 03/10/2026

Aggregate value reported $4,860,837.15 Proceeds for the 121,220 shares

Shares cited outstanding 53,993,017 shares As of 04/02/2026

Acquisition date (options) 06/07/2016 Acquired as compensation — Stock Options

Key Terms

Form 144, cashless exercise / same-day sale, acquired as compensation -- Stock Options

3 terms

Form 144 regulatory

"144: Securities To Be Sold"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

cashless exercise / same-day sale financial

"Compensation -- Cashless exercise / same-day sale"

acquired as compensation -- Stock Options financial

"Acquired as compensation -- Stock Options"

FAQ

What did IMAX's Form 144 disclose about Richard Gelfond's transaction?

It discloses a sale of 121,220 shares by Richard Gelfond on 03/10/2026. The filing reports an aggregate value of $4,860,837.15 and notes the shares were Common Stock acquired as compensation via stock options.

How large was the sale relative to IMAX's outstanding shares?

The sale represents a small fraction of outstanding shares: 121,220 versus 53,993,017 cited as of 04/02/2026. That proportion is modest and below thresholds typically considered material in insider filings.

What method of disposition is listed in the Form 144?

The Form 144 lists the transaction as a cashless exercise / same-day sale of stock options acquired as compensation. The filing attributes the securities to compensation-related option exercise dated 06/07/2016.

Does the Form 144 state who receives the proceeds from the sale?

The filing shows an aggregate value of $4,860,837.15 for the sold shares. The document does not further allocate who receives proceeds beyond identifying the reporting person and the disposal method.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 04/02/2026 - 05:06 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0000944011
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	IMAX Corporation
SEC File Number	001-35066
Address of Issuer	2525 Speakman Drive Mississauga Unknown L5K 1B1
Phone	1-905-403-6457
Name of Person for Whose Account the Securities are To Be Sold	Richard Gelfond
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Goldman Sachs & Co. LLC 200 West Street New York NY 10282	12037	483044.81	53993017	04/02/2026	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/07/2016	Acquired as compensation -- Stock Options	Issuer			12037	06/07/2016	Compensation -- Cashless exercise / same-day sale

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
Richard Gelfond 2525 Speakman Drive Mississauga XX L5K 1B1	Common	03/10/2026	121220	4860837.15

144: Remarks and Signature

Remarks	The sales of shares set forth herein are made in connection with a selling plan dated 12/9/2025, that is intended to comply with Rule 10b5-1(c).
Date of Notice	04/02/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	12/09/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	Goldman Sachs & Co. LLC on behalf of Richard Gelfond
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)